2020
DOI: 10.1080/14767058.2020.1781808
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound evaluation of subcutaneous and visceral abdominal fat as a predictor of gestational diabetes mellitus: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 42 publications
0
7
0
Order By: Relevance
“…In the case of central and visceral body fats, Benevides et al(2020) reported that the cut-off point for subcutaneous, visceral, and total abdominal fat to predict GDM varied between studies in the first and second trimesters of pregnancy. No study confirmed a model for predicting GDM using subcutaneous and visceral fat measurements [ 78 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the case of central and visceral body fats, Benevides et al(2020) reported that the cut-off point for subcutaneous, visceral, and total abdominal fat to predict GDM varied between studies in the first and second trimesters of pregnancy. No study confirmed a model for predicting GDM using subcutaneous and visceral fat measurements [ 78 ].…”
Section: Discussionmentioning
confidence: 99%
“…Two other studies show that VAT area (as extracted from a single scan obtained at the level of umbilicus, ie, approximately the level of L4-L5) was highly correlated with total VAT volume. 18 , 19 …”
Section: Methodsmentioning
confidence: 99%
“…Within the context of EC, VAT has been associated with several of its risk factors, including hypertension, 18 diabetes mellitus, 19 and polycystic ovarian syndrome. 20 A prospective epidemiologic risk factor study found that central obesity was associated with increased risk of female genital organ cancers in postmenopausal women, independent of their BMI.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…As the disease progresses, chronic inflammation is maintained and manifests as an increased myeloid cell number and a decreased lymphoid cell number, a process called skewed myelopoiesis. Skewed myelopoiesis has been demonstrated in streptozotocin-induced type 1 diabetic mice 2,3 , obese db/db mice 4 , and T2DM patients 5 . The inflammatory cells, together with proinflammatory cytokines, chemokines, and enzymes, reinforce the progression of diabetes and the resulting vascular complications.…”
mentioning
confidence: 99%